Q&A with Mark Garner: The golden age of cancer research
Drug Discovery World
JULY 5, 2023
A fulfilling part of my job is meeting the scientists, companies, and institutions at the forefront of ground-breaking research that are advancing patient health outcomes. For example, if a patient’s tumour has a particular protein present, called a checkpoint protein, this will reduce the response of T-cells.
Let's personalize your content